VCV002444166.3 - ClinVar

NM_012250.6(RRAS2):c.67G>A (p.Gly23Ser)

Germline

Classification

The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.

(3)

Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.

Conflicting classifications of pathogenicity
Likely pathogenic(2); Uncertain significance(1)

criteria provided, conflicting classifications

Somatic

No data submitted for somatic clinical impact

Somatic

No data submitted for oncogenicity

Variant Details

Identifiers

NM_012250.6(RRAS2):c.67G>A (p.Gly23Ser)

Variation ID: 2444166 Accession: VCV002444166.3

Type and length

single nucleotide variant, 1 bp

Location

Cytogenetic: 11p15.2 11: 14358804 (GRCh38) [ NCBI UCSC ] 11: 14380350 (GRCh37) [ NCBI UCSC ]

Timeline in ClinVar

	First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.	Last submission Help The date of the most recent submission for each type of classification for this variant.	Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline	Mar 18, 2023	Oct 26, 2024	Oct 15, 2024

HGVS

Nucleotide	Protein	Molecular consequence
NM_012250.6:c.67G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.	NP_036382.2:p.Gly23Ser	missense
NM_001177314.2:c.3+5587G>A		intron variant
NM_012250.5:c.67G>A
NC_000011.10:g.14358804C>T
NC_000011.9:g.14380350C>T
NG_017058.1:g.10703G>A

... more HGVS ... less HGVS

Protein change

G23S

Other names

Canonical SPDI

NC_000011.10:14358803:C:T

Functional consequence Help The effect of the variant on RNA or protein function, based on experimental evidence from submitters.

Global minor allele frequency (GMAF) Help The global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.

Allele frequency Help The frequency of the allele represented by this VCV record.

Links

VarSome

Genes

Gene	OMIM	ClinGen Gene Dosage Sensitivity Curation		Variation Viewer Help Links to Variation Viewer, a genome browser to view variation data from NCBI databases.	Related variants
Gene	OMIM	HI score Help The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.	TS score Help The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.		Within gene Help The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants.	All Help The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene.
LOC130005368	-	-	-	GRCh38	-	15
RRAS2		-	-	GRCh38 GRCh37	62	89

Conditions - Germline

Condition Help The condition for this variant-condition (RCV) record in ClinVar.	Classification Help The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions)	Review status Help The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status.	Last evaluated Help The most recent date that a submitter evaluated this variant for the condition.	Variation/condition record Help The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page.
Noonan syndrome 12	Likely pathogenic (2)	criteria provided, multiple submitters, no conflicts	Oct 15, 2024	RCV003152964.2
RRAS2-related disorder	Uncertain significance (1)	criteria provided, single submitter	Mar 9, 2023	RCV003395714.4

Submissions - Germline

Classification Help The submitted germline classification for each SCV record. (Last evaluated)	Review status Help Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria)	Condition Help The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant.	Submitter Help The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar.	More information Help This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter.
Likely pathogenic (Feb 23, 2023)	criteria provided, single submitter (ACMG Guidelines, 2015) Method: clinical testing	Noonan syndrome 12 Affected status: yes Allele origin: unknown	3billion Accession: SCV003841565.1 First in ClinVar: Mar 18, 2023 Last updated: Mar 18, 2023	Publications: PubMed (1) PubMed: 31130282 Comment: The variant is not observed in the gnomAD v2.1.1 dataset. The variant is located in a mutational hot spot and/or well-established functional domain in which … (more) The variant is not observed in the gnomAD v2.1.1 dataset. The variant is located in a mutational hot spot and/or well-established functional domain in which established pathogenic variants have been reported. Missense changes are a common disease-causing mechanism. Different missense changes at the same codon (p.Gly23Asp, p.Gly23Cys, p.Gly23Val) have been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000626911, VCV001342092, VCV001699117 / PMID: 31130282). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. (less) Clinical Features: Germinoma (present) , Short stature (present) , Panhypopituitarism (present) , Abnormal facial shape (present) , Intellectual disability (present)
Uncertain significance (Mar 09, 2023)	criteria provided, single submitter (ACMG Guidelines, 2015) Method: clinical testing	RRAS2-related condition Affected status: unknown Allele origin: germline	PreventionGenetics, part of Exact Sciences Accession: SCV004111866.1 First in ClinVar: Nov 20, 2023 Last updated: Nov 20, 2023	Comment: The RRAS2 c.67G>A variant is predicted to result in the amino acid substitution p.Gly23Ser. To our knowledge, this variant has not been reported in a … (more) The RRAS2 c.67G>A variant is predicted to result in the amino acid substitution p.Gly23Ser. To our knowledge, this variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant was observed de novo in patient with global developmental delay, central hypotonia and abnormal facial shape (Decipher; patient 292439). Other variant at this codon p. Gly23Val was reported de novo in patient with Noonan syndrome (Capri et al 2019. PubMed ID: 31130282) and another pathogenic variant at this codon p.Gly23Asp is listed in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/1699117/?new_evidence=true). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. (less)
Likely pathogenic (Oct 15, 2024)	criteria provided, single submitter (ACMG Guidelines, 2015) Method: clinical testing	Noonan syndrome 12 Affected status: yes Allele origin: germline	Institute of Immunology and Genetics Kaiserslautern Accession: SCV005382103.1 First in ClinVar: Oct 26, 2024 Last updated: Oct 26, 2024	Comment: ACMG Criteria: PP5, PM2_P, PM1, PM5; Variant was found in heterozygous state Clinical Features: Coarctation of aorta (present) , Iris coloboma (present) , Microphthalmia (present) , Clubfoot (present) , Inguinal hernia (present) , Cryptorchidism (present) , Downslanted palpebral fissures … (more) Coarctation of aorta (present) , Iris coloboma (present) , Microphthalmia (present) , Clubfoot (present) , Inguinal hernia (present) , Cryptorchidism (present) , Downslanted palpebral fissures (present) , Low-set ears (present) (less)

Comment:

The variant is not observed in the gnomAD v2.1.1 dataset. The variant is located in a mutational hot spot and/or well-established functional domain in which established pathogenic variants have been reported. Missense changes are a common disease-causing mechanism. Different missense changes at the same codon (p.Gly23Asp, p.Gly23Cys, p.Gly23Val) have been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000626911, VCV001342092, VCV001699117 / PMID: 31130282). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline.

Comment:

The RRAS2 c.67G>A variant is predicted to result in the amino acid substitution p.Gly23Ser. To our knowledge, this variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant was observed de novo in patient with global developmental delay, central hypotonia and abnormal facial shape (Decipher; patient 292439). Other variant at this codon p. Gly23Val was reported de novo in patient with Noonan syndrome (Capri et al 2019. PubMed ID: 31130282) and another pathogenic variant at this codon p.Gly23Asp is listed in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/1699117/?new_evidence=true). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

Germline Functional Evidence

There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar.

Comment:

Citations for germline classification of this variant

Title	Author	Journal	Year	Link
Activating Mutations of RRAS2 Are a Rare Cause of Noonan Syndrome.	Capri Y	American journal of human genetics	2019	PMID: 31130282

Text-mined citations for this variant ...

Record last updated Nov 03, 2024

ClinVar Genomic variation as it relates to human health

NM_012250.6(RRAS2):c.67G>A (p.Gly23Ser)

Variant Details

Genes

Conditions - Germline

Submissions - Germline

Germline Functional Evidence

Citations for germline classification of this variant

Text-mined citations for this variant ...